Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas

Epstein-Barr virus (EBV) persists in nasopharyngeal (NPC) and gastric carcinomas (EBVaGC) in a tightly latent form. Cytolytic virus activation (CLVA) therapy employs gemcitabine and valproic acid (GCb+VPA) to reactivate latent EBV into the lytic phase and antiviral valganciclovir to enhance cell dea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramayanti, Octavia, Brinkkemper, Mitch, Verkuijlen, Sandra A. W. M., Ritmaleni, Leni, Go, Mei Lin, Middeldorp, Jaap M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923344/
https://www.ncbi.nlm.nih.gov/pubmed/29565326
http://dx.doi.org/10.3390/cancers10040089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923344/
https://www.ncbi.nlm.nih.gov/pubmed/29565326
http://dx.doi.org/10.3390/cancers10040089

Ejemplares similares